Jack Phillips - 26 Apr 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Executive Officer
Signature: /s/ Steven Reichling, attorney-in-fact
Issuer symbol: AXDX
Transactions as of: 26 Apr 2022
Transactions value $: -$82,034
Form type: 4
Filing time: 28 Apr 2022, 17:54:46 UTC
Previous filing: 06 Apr 2022
Next filing: 24 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+168,396	+1.36%	$0	291,781	26 Apr 2022	Direct	F1
transaction	AXDX	Common Stock	Sale	-$82,033	-83,708	-28.69%	$0.98^*	208,073	28 Apr 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-168,396	-100%	$0^*	0	26 Apr 2022	Common Stock	168,396		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 28, 2022, the reporting person was granted a total of 168,396 restricted stock units, which vested April 26, 2022.